Kyntra Bio (KYNB) Debt Ratio (2023 - 2026)
Kyntra Bio's (KYNB) quarterly Debt Ratio came in at 0.19 in Q2 2026, down 54.13% year-over-year from 0.41 in Q2 2025, and down 54.13% quarter-over-quarter from 0.41 in Q2 2025.
Analysis
Kyntra Bio (KYNB) Debt Ratio (2023 - 2026) Analysis & Trends
Kyntra Bio has disclosed Debt Ratio across 4 years of filings, most recently posting 0.19 for Q2 2026.
- In Q2 2026, Debt Ratio fell 54.13% year-over-year to 0.19; the TTM figure through Jun 2026 stood at 0.19 (down 54.13% YoY), while the FY2024 annual figure was 0.34, up 100.6% from the prior year.
- Debt Ratio came in at 0.19 for Q2 2026 at Kyntra Bio, down from 0.41 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.44 in Q1 2025 to a low of 0.14 in Q2 2023.
- Average Debt Ratio over 4 years is 0.26, with a median of 0.22 recorded in 2024.
- Year-over-year, Debt Ratio soared 125.15% in 2025 and tumbled 54.13% in 2026.
- Over 4 years, Debt Ratio stood at 0.17 in 2023, then jumped by 100.6% to 0.34 in 2024, then advanced by 21.54% to 0.41 in 2025, then plunged by 54.13% to 0.19 in 2026.
- Per Business Quant data, the three most recent Debt Ratio figures were 0.19 in Q2 2026, 0.41 in Q2 2025, and 0.44 in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 0.66 |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 0.58 |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 0.05 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 0.05 |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 0.25 |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Kyntra Bio | 32.30 Mn | 32.30 Mn | 1.47 Mn | 0.19 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.19 |
| Jun 30, 2025 | 0.41 |
| Mar 31, 2025 | 0.44 |
| Dec 31, 2024 | 0.34 |
| Sep 30, 2024 | 0.28 |
| Jun 30, 2024 | 0.25 |
| Mar 31, 2024 | 0.20 |
| Dec 31, 2023 | 0.17 |
| Sep 30, 2023 | 0.16 |
| Jun 30, 2023 | 0.14 |